S. 2164

Referred to Committee

Lower Costs, More Cures Act of 2021

Introduced 6/22/2021•117th Congress•Senate

Congress.gov

Latest Action

Read twice and referred to the Committee on Finance.

6/22/2021 • Senate

Summary

Lower Costs, More Cures Act of 2021

This bill establishes and modifies several programs and requirements to address prescription drug prices, particularly in relation to Medicare and Medicaid.

Among other changes, the bill

requires the Centers for Medicare & Medicaid Services to publish certain information, as reported by pharmacy benefit managers (PBMs), relating to generic dispensing rates, drug discounts and rebates, and payments between PBMs, health plans, and pharmacies;
caps annual out-of-pocket spending under the Medicare prescription drug benefit;
allows prescription drug plan sponsors under the Medicare prescription drug benefit to offer additional plans in a region;
establishes requirements under the Medicaid Drug Rebate Program for certain gene therapies for which prices are indexed to achieved outcomes; and
establishes the position of Chief Pharmaceutical Negotiator in the Office of the U.S. Trade Representative.

Introduced in Senate • 6/22/2021

Enter your district to see how this bill affects your community

Topics & Subjects

Policy Area: Health

Business recordsCivil actions and liabilityCongressional oversightConsumer affairsDepartment of Health and Human ServicesDigestive and metabolic diseasesDrug safety, medical device, and laboratory regulationDrug therapyExecutive agency funding and structureFood and Drug Administration (FDA)Fraud offenses and financial crimesGeneticsGovernment information and archivesGovernment studies and investigationsHealth care costs and insuranceHealth care coverage and accessHealth care qualityHealth personnelHealth promotion and preventive care